What is Reiter syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Reiter Syndrome?

Reiter syndrome, now called reactive arthritis, is a post-infectious inflammatory condition characterized by the classic triad of arthritis, urethritis, and conjunctivitis that develops after urogenital (typically chlamydial) or gastrointestinal infections, predominantly affecting HLA-B27 positive young men. 1, 2

Clinical Definition and Terminology

  • The term "Reiter syndrome" has been replaced with "reactive arthritis" for both ethical reasons (Hans Reiter's Nazi affiliations) and clinical utility, though the eponym persists in medical literature 3
  • Reactive arthritis is defined as an infection-induced systemic illness with inflammatory synovitis from which no viable microorganisms can be cultured 4
  • The complete Reiter triad (urethritis, conjunctivitis, arthritis) occurs in only 41.7% of patients; 44.2% present with two of three features, making "reactive arthritis" a more inclusive term 5, 4

Epidemiology and Risk Factors

  • The condition predominantly affects young men with a male-to-female ratio of 8.5:1 5
  • Frequency in the United States is estimated at 3.5 to 5 cases per 100,000 population 2
  • HLA-B27 is present in 83.3% of patients, indicating strong genetic susceptibility 5
  • The disease occurs after urogenital infections (77.5% of cases) or enteric infections (16.5% of cases) 5

Pathophysiology and Causative Organisms

  • Chlamydia trachomatis is the most common urogenital trigger, found in synovial fluid in 54% of tested patients 5
  • Ureaplasma urealyticum and Mycoplasma genitalium have been implicated in urethritis-associated cases 6, 7
  • Enteric organisms can cause reactive arthritis, particularly in men over 35 years or those practicing insertive anal intercourse 7
  • The finding of causative agents in synovial membrane or fluid suggests an infectious rather than purely reactive process 5

Clinical Manifestations

Musculoskeletal Features

  • Asymmetrical oligoarthritis of lower extremities is the most frequent presentation, occurring in 69.4% of patients 5
  • The arthritis is typically acute or subacute (40.5%), though recurrent (31%) and chronic forms (28.5%) occur 5

Genitourinary Features

  • Urethritis with mucopurulent discharge, dysuria, or urethral pruritis 8
  • In rare instances, men may develop urethral strictures 6
  • Circinate balanitis and ulcerative vulvitis can occur 1

Ocular Features

  • Conjunctivitis is treated with artificial tears containing methylcellulose or hyaluronate 9
  • Iritis may develop in some patients 3

Dermatologic Features

  • Keratoderma blennorrhagicum (hyperkeratotic skin lesions) 1
  • Nail changes and oral lesions are common 1

Management Approach

Initial Treatment Strategy

NSAIDs should be initiated as first-line therapy, followed by disease-modifying antirheumatic drugs (DMARDs) for persistent symptoms, with antibiotics indicated when there is evidence of ongoing infection. 9

Antibiotic Therapy

  • For documented Chlamydia trachomatis infection: Doxycycline 100 mg orally twice daily for 7 days to potentially shorten the course or prevent onset of arthritis 9, 8
  • For suspected chlamydial or gonococcal infection: Ceftriaxone 250 mg IM single dose PLUS Doxycycline 100 mg orally twice daily for 10 days 7
  • Alternative for enteric organisms or antibiotic allergies: Ofloxacin 300 mg orally twice daily for 10 days OR Levofloxacin 500 mg orally once daily for 10 days 7

Symptomatic Management

  • Ocular symptoms: artificial tears with methylcellulose or hyaluronate 9
  • Avoid anticholinergic medications as they worsen sicca symptoms in patients with ocular involvement 9
  • Use corticosteroids at minimum effective dose and duration to avoid significant side effects 9

Critical Clinical Pitfalls

  • Do not delay treatment: Without proper management, reactive arthritis can progress to chronic destructive arthritis in 15-20% of patients 1, 2
  • Reassess if no improvement: Failure to improve within 3 days of treatment requires reevaluation of both diagnosis and therapy 7
  • Partner management is essential: Sexual partners should be evaluated and treated if the condition is caused by sexually transmitted pathogens 7
  • Enforce sexual abstinence: Patients must avoid sexual intercourse until they and their partners are cured 7
  • Consider HIV status: Treatment is particularly difficult in HIV-positive patients, who may have more severe disease 1

Prognosis

  • Clinical presentation, severity, and prognosis vary widely 1
  • 15% to 20% of patients may develop severe chronic sequelae 1
  • Prompt recognition and early intervention lead to better outcomes with fewer complications 2

References

Research

Reiter's syndrome: the classic triad and more.

Journal of the American Academy of Dermatology, 2008

Research

An overview of reactive arthritis.

JAAPA : official journal of the American Academy of Physician Assistants, 2019

Research

Reiter's syndrome and reactive arthritis.

The Journal of the American Osteopathic Association, 2000

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Seminal Vesiculitis Causes and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ureaplasma Infection Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Reiter's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.